Discontinuation and Predictors of Distnea with Tycagrelor

In this week’s View, Dr. Eagle explores the impact of residual ischemia on cardiovascular mortality in left main bifurcation stenting. He then discusses coronary revascularization guided by instantaneous wave free ratio vs. fractional flow reserve and 5-year mortality. Finally, Dr. Eagle examines dyspnea-related ticagrelor discontinuation after percutaneous coronary intervention. 

Subscribe to Eagle’s Eye View